The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer
Abstract
Progression through the cell cycle is governed by cyclin-dependent kinases (cdks), whose activity is inhibited by the cdk inhibitors. Cyclins, cdks, and cdk inhibitors are frequently deregulated in cancers. This chapter reviews the prognostic significance of alterations in cdk inhibitors. Loss of p27 protein provides independent prognostic information in breast, prostate, colon, and gastric carcinomas, and immunohistochemical (IHC) staining for p27 may eventually become part of routine histopathologic processing of cancers. Loss of IHC staining for p21 may be prognostic in certain cancers but conflicting results are reported in breast cancer. Reports on homozygous deletion of p16 and p15 genes suggest the value of larger, prospective studies with standardized treatment protocols to definitively establish the prognostic utility of p15/p16 deletions in acute leukemias. Larger trials and the development of a consensus on methods for deletion analysis, IHC staining, and tumor scoring will be needed to move these molecular assays from bench to bedside.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Research works printed but not linked: 27
- 10.1006/scbi.1995.0010 · doi:10.1006/scbi.1995.0010
- Gillett C, 1994, Cancer Res., 54, 1812
- 10.1002/path.1711720303 · doi:10.1002/path.1711720303
- Buckley MF, 1993, Oncogene, 8, 2127
- Lovec H, 1994, Oncogene, 9, 323
- Kawamata N, 1995, Cancer Res., 55, 2266
- Ponce-Castaneda MV, 1995, Cancer Res., 55, 1211
- Pietenpol JA, 1995, Cancer Res., 55, 1206
- Tan P, 1997, Cancer Res., 57, 1259
- Guo Y, 1997, Clin. Cancer Res., 3, 2269
- Tsihlias J, 1998, Cancer Res., 58, 542
- 10.1097/00005392-199803000-00088 · doi:10.1097/00005392-199803000-00088
- Esposito V, 1997, Cancer Res., 57, 3381
- Singh SP, 1998, Cancer Res., 58, 1730
- 10.1093/ajcp/107.6.684 · doi:10.1093/ajcp/107.6.684
- 10.1002/(SICI)1097-0215(19971021)74:5<529::AID-IJC9>3.0.CO;2-5 · doi:10.1002/(sici)1097-0215(19971021)74:5<529::aid-ijc9>3.0.co;2-5
- Johnson EA, 1996, Proc. Am. Assoc. Cancer Res., 37, 569
- 10.1038/bjc.1981.168 · doi:10.1038/bjc.1981.168
- Moelandsmo GM, 1996, Am. J. Pathol., 149, 1813
- 10.1097/00004347-199710000-00011 · doi:10.1097/00004347-199710000-00011
- 10.1002/(SICI)1096-9896(199711)183:3<318::AID-PATH925>3.0.CO;2-0 · doi:10.1002/(sici)1096-9896(199711)183:3<318::aid-path925>3.0.co;2-0
- 10.1002/(SICI)1097-0215(19970822)74:4<383::AID-IJC4>3.0.CO;2-R · doi:10.1002/(sici)1097-0215(19970822)74:4<383::aid-ijc4>3.0.co;2-r
- Pollak C, 1987, Leukemia, 1, 541
- 10.1038/sj.leu.2400833 · doi:10.1038/sj.leu.2400833
- 10.1002/(SICI)1097-0142(19970801)80:3<389::AID-CNCR6>3.0.CO;2-N · doi:10.1002/(sici)1097-0142(19970801)80:3<389::aid-cncr6>3.0.co;2-n
- Kratzke RA, 1996, Cancer Res., 56, 3415
- 10.1002/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO;2-F · doi:10.1002/(sici)1097-0215(19970220)74:1<57::aid-ijc10>3.0.co;2-f
Cited by
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,237
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Chu, I. M., Hengst, L., & Slingerland, J. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2347 · Cited by 990
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J.-H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. (2002) · Nature Medicine · doi:10.1038/nm761 · Cited by 948
Ubiquitin-mediated proteolysis: biological regulation via destruction
Ciechanover, A., Orian, A., & Schwartz, A. L. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200005)22:5<442::aid-bies6>3.0.co;2-q · Cited by 853
Metadata
- Authors
- Tsihlias, M., Kapusta, M., & Slingerland, M.
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 1999-02
- Volume
- 50
- Issue
- 1
- Pages
- 401-423
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2131954674
- Cited by
- 319
- References
- 82
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer. https://app.cochat.ai/papers/10.1146/annurev.med.50.1.401
- The paper
- Tsihlias, M., Kapusta, M., & Slingerland, M. (1999). The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer. Annual Review of Medicine. https://doi.org/10.1146/annurev.med.50.1.401
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.